EMERALD ADVISERS, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001015083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q3 2025 · 257 positions · Total reported value $3.12B · Top-10 concentration 21.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.0% · 14 new · 86 cut · 28 exited

Active Share (vs S&P 500): 97.9% · vs QQQ: 98.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -14.5% · vs SPY -16.6% · Prev Value $4.25B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.4% · vs SPY -6.6% · Latest Value $3.63B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, EMERALD ADVISERS, LLC disclosed 257 equity positions with a combined reported value of $3.12B. The filing implies a diversified portfolio: its ten largest positions account for 21.1% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q3 2025 were KTOS ($88.52M), CRDO ($86.95M), AVAV ($77.94M). By sector, the heaviest allocations are Technology 25.5%, Health Care 20.1%. Versus the prior quarter, allocation shifted toward Energy (+2.3pp), Technology (+1.4pp) and away from Other (-1.9pp), Financials (-2.1pp).

Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 86% of names.

The largest new positions opened in Q3 2025 were SMTC ($29.94M), AGX ($23.37M), EVLV ($19.78M).

Of the 28 positions fully exited versus the prior quarter, the largest were GTLS ($17.95M), FORM ($16.31M), MARA ($9.09M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • SMTC SEMTECH CORP · $29.94M
  • AGX ARGAN INC · $23.37M
  • EVLV EVOLV TECHNOLOGIES HLDNGS IN · $19.78M
  • NKTR NEKTAR THERAPEUTICS · $18.39M
  • HIMS HIMS & HERS HEALTH INC · $17.35M
  • CUBI CUSTOMERS BANCORP INC · $15.15M
  • VC VISTEON CORP · $14.12M
  • COMP COMPASS INC · $12.75M

Fully Exited (vs previous quarter)

  • GTLS CHART INDS INC · prev qtr: $17.95M
  • FORM FORMFACTOR INC · prev qtr: $16.31M
  • MARA MARA HOLDINGS INC · prev qtr: $9.09M
  • SPT SPROUT SOCIAL INC · prev qtr: $5.20M
  • FLOC FLOWCO HLDGS INC · prev qtr: $3.85M
  • LOAR LOAR HOLDINGS INC · prev qtr: $998.02K
  • ORRF ORRSTOWN FINL SVCS INC · prev qtr: $292.61K
  • AMBA AMBARELLA INC · prev qtr: $235.06K

Insider Transactions (Form 4)

Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: LEOLA, PA, United States
  • SEC registration: 801-40263 (status: Approved), registered 1991-11-25
  • Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Website: teamemerald.com

Portfolio Structure

  • 237 positions · $4.25B reported value (Q2 2026)
  • Top 10 holdings = 17.4% of reported value
  • Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
  • Average position size: $17.93M

Sector Tilt

  • Information Technology 26.5%
  • Health Care 21.7%
  • Consumer Discretionary 19.5%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
  • 52 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 25.5%
Health Care 20.1%
Industrials 11.8%
Financials 10.8%
Energy 2.3%
Other 9.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 968.85K $88.52M 2.84%
2.84%
Reduce
2 597.13K $86.95M 2.79%
2.79%
Reduce
3 247.51K $77.94M 2.50%
2.50%
Reduce
4 637.75K $66.45M 2.13%
2.13%
Reduce
5 363.62K $59.16M 1.90%
1.90%
Reduce
6 1.01M $58.04M 1.86%
1.86%
Reduce
7 684.95K $57.93M 1.86%
1.86%
Add
8 391.72K $55.69M 1.78%
1.78%
Add
9 873.20K $54.56M 1.75%
1.75%
Add
10 910.64K $52.33M 1.68%
1.68%
Reduce
11 2.15M $51.31M 1.65%
1.65%
Add
12 642.17K $48.94M 1.57%
1.57%
Reduce
13 162.24K $48.89M 1.57%
1.57%
Add
14 1.58M $46.09M 1.48%
1.48%
Reduce
15 602.58K $45.13M 1.45%
1.45%
Reduce
16 528.91K $44.77M 1.44%
1.44%
Reduce
17 387.59K $43.49M 1.39%
1.39%
Reduce
18 627.76K $42.44M 1.36%
1.36%
Reduce
19 533.09K $41.26M 1.32%
1.32%
Add
20 990.62K $40.76M 1.31%
1.31%
Reduce
21 110.67K $40.35M 1.29%
1.29%
Reduce
22 301.02K $38.65M 1.24%
1.24%
Reduce
23 720.34K $37.41M 1.20%
1.20%
Reduce
24 223.29K $37.12M 1.19%
1.19%
Reduce
25 502.95K $36.41M 1.17%
1.17%
Reduce
26 301.00K $35.14M 1.13%
1.13%
Reduce
27 101.78K $35.14M 1.13%
1.13%
Reduce
28 329.98K $34.73M 1.11%
1.11%
Reduce
29 364.88K $32.72M 1.05%
1.05%
Add
30 684.74K $32.57M 1.04%
1.04%
Reduce
31 451.50K $32.20M 1.03%
1.03%
Reduce
32 521.18K $30.95M 0.99%
0.99%
Add
33 419.09K $29.94M 0.96%
0.96%
New
34 141.42K $29.85M 0.96%
0.96%
Add
35 156.89K $29.62M 0.95%
0.95%
Add
36 1.73M $29.40M 0.94%
0.94%
Reduce
37 551.16K $28.87M 0.93%
0.93%
Add
38 153.51K $28.67M 0.92%
0.92%
Add
39 457.78K $28.15M 0.90%
0.90%
Add
40 155.23K $28.06M 0.90%
0.90%
Reduce
41 82.58K $28.05M 0.90%
0.90%
Add
42 1.34M $27.48M 0.88%
0.88%
Add
43 369.60K $27.10M 0.87%
0.87%
Add
44 160.16K $26.54M 0.85%
0.85%
Reduce
45 1.14M $26.45M 0.85%
0.85%
Add
46 427.72K $25.99M 0.83%
0.83%
Add
47 313.09K $25.47M 0.82%
0.82%
Reduce
48 1.33M $24.86M 0.80%
0.80%
Reduce
49 209.56K $24.80M 0.80%
0.80%
Reduce
50 616.72K $24.65M 0.79%
0.79%
Reduce

FAQ

What did EMERALD ADVISERS, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, EMERALD ADVISERS, LLC reported 257 equity positions worth $3.12B in aggregate; its largest disclosed positions were KTOS ($88.52M), CRDO ($86.95M), AVAV ($77.94M).

How large is EMERALD ADVISERS, LLC's portfolio?

EMERALD ADVISERS, LLC reported $3.12B of long equity holdings across 257 positions as of 2025-Q3. Top-10 holdings account for 21.1% of reported value.

What is EMERALD ADVISERS, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/emerald-advisers/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →